Insights

Global Presence CellCarta operates across North America, Europe, Asia, and Australia, providing an extensive geographical footprint that can facilitate multinational clinical trials and offer localized support, creating opportunities for partnerships with global and regional biotech firms.

Technological Innovation Recent integrations with advanced AI, NGS-based proteomics, and pathology technologies demonstrate CellCarta’s commitment to innovation, making it an attractive partner for clients seeking cutting-edge solutions for biomarker discovery, assay development, and diagnostic testing.

Collaborative Growth Strategic collaborations with companies like Leica Biosystems, Biofidelity, and Lunit Inc. indicate a willingness to expand service offerings and adopt new technologies, which presents opportunities to cross-sell or co-develop new testing solutions for emerging markets.

Regulatory Expertise CellCarta’s accredited laboratories supporting CAP, CLIA, ISO15189, and other standards ensure compliance with regulatory requirements, making it a reliable partner for companies looking to develop and commercialize globally compliant diagnostic and research assays.

Market Expansion Recent initiatives such as launching a Chinese mobile website and WeChat Mini-Program highlight efforts to increase visibility and engagement within the growing biopharmaceutical community in China, creating potential for regional partnerships and sales in high-growth markets.

CellCarta Tech Stack

CellCarta uses 8 technology products and services including Linkedin Insight Tag, Microsoft SQL Server, MySQL, and more. Explore CellCarta's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Microsoft SQL Server
    Database
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Microsoft Dynamics
    Enterprise Resource Planning
  • ZoomInfo
    Lead Generation
  • WeChat
    Social Media Marketing Software
  • TablePress
    Web Platform Extensions

Media & News

CellCarta's Email Address Formats

CellCarta uses at least 1 format(s):
CellCarta Email FormatsExamplePercentage
First.Last@cellcarta.comJohn.Doe@cellcarta.com
91%
FLast@cellcarta.comJDoe@cellcarta.com
4%
First.MiddleLast@cellcarta.comJohn.MichaelDoe@cellcarta.com
4%
FirstLast@cellcarta.comJohnDoe@cellcarta.com
1%

Frequently Asked Questions

What is CellCarta's official website and social media links?

Minus sign iconPlus sign icon
CellCarta's official website is cellcarta.com and has social profiles on LinkedIn.

What is CellCarta's SIC code NAICS code?

Minus sign iconPlus sign icon
CellCarta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CellCarta have currently?

Minus sign iconPlus sign icon
As of January 2026, CellCarta has approximately 745 employees across 5 continents, including North AmericaEuropeOceania. Key team members include Chief Financial Officer: E. M.Chief Human Resources Officer & General Counsel: N. E. S.Chief Information Officer: L. N.. Explore CellCarta's employee directory with LeadIQ.

What industry does CellCarta belong to?

Minus sign iconPlus sign icon
CellCarta operates in the Biotechnology Research industry.

What technology does CellCarta use?

Minus sign iconPlus sign icon
CellCarta's tech stack includes Linkedin Insight TagMicrosoft SQL ServerMySQLMicrosoft ExcelMicrosoft DynamicsZoomInfoWeChatTablePress.

What is CellCarta's email format?

Minus sign iconPlus sign icon
CellCarta's email format typically follows the pattern of First.Last@cellcarta.com. Find more CellCarta email formats with LeadIQ.

When was CellCarta founded?

Minus sign iconPlus sign icon
CellCarta was founded in 2000.

CellCarta

Biotechnology ResearchQuebec, Canada501-1000 Employees

As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. 

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services.

At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications.


Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO27001 and ISO13485.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
501-1000

Section iconFunding & Financials

  • $100M$250M

    CellCarta's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    CellCarta's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.